Skip to main content

August 2023

 

 

academics

 

Clinical research courses

Vacancy for Ph.D or M.Pharm, MSc in Quality Control at VBPL

VBPL is an ISO 13485:2012 and WHO – GMP certified leading global player in Biopharma sector having more than 15 years of operational experience, situated at Hyderabad. We also have offices located in USA. Innovative, ever motivated Research team and uncompromising manufacturing team in providing quality products are our strengths.

Post : Sr Manager or Asst General Manager

Walk in for M.Pharm, B.Pharm, MSc in QA, QC at Alembic Pharmaceuticals

Legacy of Alembic Pharmaceuticals Limited (APL) dates back to over 100 years. Established in 1907 with an objective to develop and revolutionize the Pharmaceutical and Drug industry in the Indian subcontinent, Alembic Pharmaceuticals Limited today is one of the leading pharmaceutical companies in India.

Alembic Pharma looking for competent young professionals to be an integral part of our team for our API Manufacturing Sites at Panelav / Karakhadi near Vadodara (Gujarat).

Walk in for M.Pharm, B.Pharm, MSc in Production, QA, QC at Zydus Life sciences

After a journey of growth spanning 27 years as Cadila Healthcare Ltd. and the Zydus Group, we have evolved and transformed ourselves in response to the changing times. Our legacy of over 70 years in healthcare and being dedicated to life in all its dimensions is reaffirmed in our new mission, vision and purpose. Unifying ourselves under the Zydus name, Cadila Healthcare Ltd., is renamed as Zydus Lifesciences Ltd.

Inviting candidates for our Formulation Manufacturing Plant.

Intas Pharma Walk in Drive for M.Pharm, B.Pharm, MSc in Quality Control, Manufacturing

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing and marketing companies in the world. Today, Intas is present in more than 85 countries worldwide and is growing at 20% CAGR. Around 70% of its revenues come from the international markets, particularly the highly regulated markets of EU and US. At Intas, every day and everyone works to create a world of good health, happinessand hope.

Manufacturing

Pharmaffiliates Virtual Recruitment Drive for Synthesis R&D, Analytical R&D

Pharmaffiliates is a Contract Research and Development Organization (CRDO) having presence and research centres in India, USA, Europe & Canada. Pharmaffiliates offer Synthesis of research molecules in addition to Pharmacopoeial and Non-Pharmacopoeial standards, with catalogue of 80,000 high purity research molecules across a vast range of categories With a team of 350+ people and delivering services for more than two decades and our clientele spreads in more than 90 countries worldwide.

Walk in for M.Pharm, B.Pharm, MSc in QA, QC, R&D at Leben Life Sciences

Leben Life Sciences Pvt. Ltd. (LLS) is an established pharmaceutical formulation company for more than four decades. LLS has following openings for its EU-GMP Approved Global Standard OSD & Semi-solids Formulation manufacturing facility at Akola (M.S.)

Interview for M.Pharm, B.Pharm in QA, PPIC, Export, RA, F&D Department at Bharat Parenterals Ltd

Bharat Parenterals Ltd. is a Gujarat based pharmaceutical company, established in 1992 by Mr. Ramesh Desai, who started the company with a vision of making world class affordable medicines and to take it to the forefront of contract manufacturing units in Gujarat.

Brown University Hiring Molecular Research Scientists

Founded in 1764, Brown is a nonprofit leading research university, home to world-renowned faculty, and also an innovative educational institution where the curiosity, creativity and intellectual joy of students drives academic excellence.  The spirit of the undergraduate Open Curriculum infuses every aspect of the University. Brown is a place where rigorous scholarship, complex problem-solving and service to the public good are defined by intense collaboration, intellectual discovery and working in ways that transcend traditional boundaries.

Daiichi Sankyo announced that ENHERTU (trastuzumab deruxtecan) has been approved in Japan

Daiichi Sankyo announced that ENHERTU® (trastuzumab deruxtecan) has been approved in Japan for the treatment of adult patients with unresectable advanced or recurrent non-small cell lung cancer (NSCLC) with HER2 (ERBB2) mutations that has progressed after chemotherapy.

New antibiotic from microbial dark matter could be powerful weapon against superbugs

Antimicrobial resistance is a major problem for human health and researchers worldwide are looking for new solutions. “We urgently need new antibiotics to combat bacteria that become increasingly resistant to most clinically used antibiotics,” says Dr. Markus Weingarth, a researcher from the Chemistry Department of Utrecht University.